BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kohnken R, Mishra A. MicroRNAs in Cutaneous T-Cell Lymphoma: The Future of Therapy. J Invest Dermatol 2019;139:528-34. [PMID: 30686578 DOI: 10.1016/j.jid.2018.10.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Khan AQ, Ahmad F, Raza SS, Zarif L, Siveen KS, Sher G, Agha MV, Rashid K, Kulinski M, Buddenkotte J, Uddin S, Steinhoff M. Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases. Seminars in Cancer Biology 2020. [DOI: 10.1016/j.semcancer.2020.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Neagu M, Constantin C, Cretoiu SM, Zurac S. miRNAs in the Diagnosis and Prognosis of Skin Cancer. Front Cell Dev Biol 2020;8:71. [PMID: 32185171 DOI: 10.3389/fcell.2020.00071] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
3 Lai P, Wang Y. Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials. Cancer Biol Med 2021;18:34-51. [PMID: 33628583 DOI: 10.20892/j.issn.2095-3941.2020.0216] [Reference Citation Analysis]
4 Li C, Wang N, Rao P, Wang L, Lu D, Sun L. Role of the microRNA-29 family in myocardial fibrosis. J Physiol Biochem 2021;77:365-76. [PMID: 34047925 DOI: 10.1007/s13105-021-00814-z] [Reference Citation Analysis]
5 Iżykowska K, Rassek K, Korsak D, Przybylski GK. Novel targeted therapies of T cell lymphomas. J Hematol Oncol 2020;13:176. [PMID: 33384022 DOI: 10.1186/s13045-020-01006-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Lin YX, Wang Y, Blake S, Yu M, Mei L, Wang H, Shi J. RNA Nanotechnology-Mediated Cancer Immunotherapy. Theranostics 2020;10:281-99. [PMID: 31903120 DOI: 10.7150/thno.35568] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
7 Bresin A, Caprini E, Russo G, Narducci MG. Challenging Cutaneous T-Cell Lymphoma: What Animal Models Tell us So Far. J Invest Dermatol 2022:S0022-202X(21)02615-4. [PMID: 35000751 DOI: 10.1016/j.jid.2021.12.007] [Reference Citation Analysis]
8 Malla WA, Arora R, Khan RIN, Mahajan S, Tiwari AK. Apoptin as a Tumor-Specific Therapeutic Agent: Current Perspective on Mechanism of Action and Delivery Systems. Front Cell Dev Biol 2020;8:524. [PMID: 32671070 DOI: 10.3389/fcell.2020.00524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]